v3.23.2
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development (including related party amounts of $258, $216, $517 and $442, respectively) $ 17,064 $ 11,295 $ 32,794 $ 20,054
General and administrative (including related party amounts of $135, $129, $270 and $254, respectively) 5,532 4,344 11,453 8,955
Total operating expenses 22,596 15,639 44,247 29,009
Loss from operations (22,596) (15,639) (44,247) (29,009)
Other income, net 2,659 640 5,016 745
Net loss $ (19,937) $ (14,999) $ (39,231) $ (28,264)
Net loss per share, basic $ (0.36) $ (0.27) $ (0.7) $ (0.51)
Net loss per share, diluted $ (0.36) $ (0.27) $ (0.7) $ (0.51)
Weighted-average shares of common stock outstanding, basic 55,948,990 55,670,780 55,928,625 55,589,510
Weighted-average shares of common stock outstanding, diluted 55,948,990 55,670,780 55,928,625 55,589,510